REAL.NASDAQTherealreal, INC

SCHEDULE 13D/A: Kanen Wealth Management Group Reduces Stake in TheRealReal Below 5%

Sentiment:

Beneficial Ownership Amendment


An investor group led by Kanen Wealth Management LLC has significantly reduced its beneficial ownership in TheRealReal, Inc., falling below the 5% threshold as of January 28, 2025.

Summary

  • Philotimo Fund, LP, Philotimo Focused Growth & Income Fund (PHLOX), Kanen Wealth Management LLC (KWM), and David Kanen, collectively referred to as the Reporting Persons, have amended their Schedule 13D filing for TheRealReal, Inc. (TRRR).
  • The Reporting Persons ceased to be beneficial owners of more than 5% of TheRealReal's common stock as of January 28, 2025.
  • As of January 30, 2025, Philotimo Fund, LP beneficially owned 1,865,676 shares, representing approximately 1.7% of the class.
  • As of January 30, 2025, Philotimo Focused Growth & Income Fund beneficially owned 1,538,285 shares, representing approximately 1.4% of the class.
  • As of January 30, 2025, Kanen Wealth Management LLC beneficially owned 4,273,959 shares, representing approximately 3.9% of the class.
  • As of January 30, 2025, David Kanen beneficially owned 4,296,153 shares, representing approximately 3.9% of the class.
  • The aggregate percentage of shares owned is based on 109,691,196 shares outstanding as of October 30, 2024, as reported in TheRealReal's Form 10-Q filed on November 4, 2024.
  • Significant sales of common stock occurred in January 2025, including 1,630,289 shares sold by Philotimo Fund, LP, 403,575 shares sold by Philotimo Focused Growth & Income Fund, and 500 shares sold by Kanen Wealth Management, LLC through Managed Accounts.
  • The shares were historically purchased using working capital and funds for customer accounts, which may have included margin loans.

Sentiment

Score: 3

Explanation: The sentiment is negative as a significant investor group has reduced its stake below the 5% threshold, indicating a divestment of a substantial portion of their holdings in TheRealReal, Inc.

Negatives

  • The Reporting Persons, a significant investor group, have reduced their stake in TheRealReal, Inc. below the 5% beneficial ownership threshold.
  • The reduction in ownership involved substantial sales of common stock by Philotimo Fund, LP (1,630,289 shares), Philotimo Focused Growth & Income Fund (403,575 shares), and Kanen Wealth Management, LLC (500 shares from Managed Accounts) throughout January 2025.

Future Outlook

The document does not contain any forward-looking statements or guidance provided by TheRealReal, Inc. or the Reporting Persons regarding the company's future performance.

Industry Context

This filing is a disclosure of a change in beneficial ownership by an institutional investor group, rather than a company performance report. It does not provide specific analysis of broader industry trends or competitors for TheRealReal, Inc.

Stakeholder Impact

  • Shareholders: The reduction in stake by a notable investor group may be perceived negatively by other shareholders, potentially impacting investor confidence and the company's stock price.

Key Dates

DateDescription
2024-10-30Date as of which 109,691,196 shares of TheRealReal, Inc. common stock were reported outstanding in the Issuer's Quarterly Report on Form 10-Q.
2024-11-04Date TheRealReal, Inc. filed its Quarterly Report on Form 10-Q with the SEC.
2025-01-07Philotimo Fund, LP sold 32,052 shares of common stock at $10.2070 per share.
2025-01-17Kanen Wealth Management, LLC (through Managed Accounts) sold 500 shares of common stock at $9.4450 per share.
2025-01-22Philotimo Fund, LP sold 2,042 shares of common stock at $9.8500 per share.
2025-01-23Philotimo Fund, LP sold 50,227 shares of common stock at $9.8118 per share.
2025-01-24Philotimo Fund, LP sold 21,786 shares of common stock at $9.5014 per share.
2025-01-28Date Reporting Persons ceased to be beneficial owners of more than 5% of TheRealReal, Inc. shares. Philotimo Fund, LP sold 1,316,331 shares at $9.6119 per share. Philotimo Focused Growth & Income Fund sold 243,547 shares at $9.6119 per share.
2025-01-29Philotimo Fund, LP sold 111,855 shares of common stock at $9.5396 per share. Philotimo Focused Growth & Income Fund sold 86,119 shares at $9.5396 per share.
2025-01-30Philotimo Fund, LP sold 95,996 shares of common stock at $9.5824 per share. Philotimo Focused Growth & Income Fund sold 73,909 shares at $9.5824 per share. Date of filing of this Schedule 13D Amendment No. 2.

Recommendation

sell

Keywords

TheRealReal, TRRR, Schedule 13D, beneficial ownership, institutional investor, stock sales, Philotimo Fund, Kanen Wealth Management, investor stake

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.